Osaka Medical Center for Cancer and Cardiovascular Diseases
2 clinical trials · Sponsor
◉ Watch Osaka Medical Center for Cancer and Cardiovascular Diseases
| Record | Firm | Date |
|---|---|---|
| A Study of Chemoradiotherapy Using Gem Plus Nab-paclitaxel for Pancreatic Cancer (NCT02272738) | Osaka Medical Center for Cancer and Cardiovascular Diseases | 2013-08-01 |
| Chemoradiotherapy With Gemcitabine/S-1 vs Gemcitabine/S-1 for Locally Advanced Pancreatic Cancer (NCT01430052) | Osaka Medical Center for Cancer and Cardiovascular Diseases | 2009-04-01 |
Track Osaka Medical Center for Cancer and Cardiovascular Diseases automatically
Every clearance here is in the API, with alerts when new ones post.